GHRL and Cachexia: Grafted liposomes associated with the nose-to-brain administration route improves ghrelin transmucosal permeation for targeting and increasing ghrelin protection against enzymatic biodegradation, pH, and ciliary clearance, which is promising in the treatment of cachexia [14].